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Abstract Pregnancy-associated plasma protein-A (PAPP-A)
has recently been identified as the proteinase responsible for
cleavage of insulin-like growth factor binding protein (IGFBP)-4,
an inhibitor of IGF action, in several biological fluids. Cleavage
of IGFBP-4 by PAPP-A is believed to occur only in the presence
of IGF. We here report that in addition to IGFBP-4, PAPP-A
also cleaves IGFBP-5. Cleavage occurs at one site, between Ser-
143 and Lys-144 of IGFBP-5. In the presence of IGF, IGFBP-4
and -5 are cleaved with similar rates by PAPP-A. Interestingly,
cleavage of IGFBP-5 by PAPP-A does not require the presence
of IGF, but is slightly inhibited by IGF. These findings have
implications for the mechanism of proteolysis of IGFBP-4 by
PAPP-A, suggesting that IGFBP-4 binds IGF, which then
becomes a PAPP-A substrate. Using highly purified, recombi-
nant proteins, we establish that (1) PAPP-A cleavage of IGFBP-
4 can occur in the absence of IGF, although the rate of hydrolysis
is very slow, and (2) IGF is unable to bind to PAPP-A. We thus
conclude that IGF enhances proteolysis by binding to IGFBP-4,
not by interaction with PAPP-A, which could not previously be
ruled out. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The biological activity of insulin-like growth factors
(IGFs)-I and -II [1] is tightly regulated by six di¡erent, but
homologous, IGF binding proteins (IGFBP-1^6) [2,3]. Cleav-
age in the central region of IGFBPs causes dissociation of
bound IGF, and such limited proteolysis is a powerful means
by which the bioavailable concentration of IGF is locally
regulated [4,5]. Although a large number of biological £uids
and conditioned media have been shown to contain speci¢c
proteolytic activity against one or more of the IGFBPs, the
identities of the proteinases have remained unknown in most
cases. One exception is the IGFBP-4 proteinase secreted by
human ¢broblasts, which has recently been identi¢ed as preg-
nancy-associated plasma protein-A (PAPP-A), a high-molec-
ular-weight protein not previously connected with the IGF
system [6]. Several other sources of IGFBP-4 proteolytic ac-
tivity have now been investigated, and PAPP-A has been
shown to be the responsible proteinase [6^10].
Based primarily on the presence of an elongated zinc-bind-
ing motif in the amino acid sequence, PAPP-A belongs to the
metzincin superfamily of metalloproteinases [11^13]. The
PAPP-A monomer of 1547 residues is secreted as a dimer of
400 kDa [6,8], but in pregnancy serum the majority of PAPP-
A (s 99%) is found in a 2:2 disul¢de bound complex with the
proform of eosinophil major basic protein [8,14], which func-
tions as a proteinase inhibitor [8]. Except for a recently dis-
covered homolog, PAPP-A2, which cleaves IGFBP-5 [15],
PAPP-A does not show global similarity to any known pro-
teins. IGFBP-4 is the only known PAPP-A substrate.
Intriguingly, cleavage of IGFBP-4 by PAPP-A is believed to
occur only in the presence of IGF. Since this observation was
made [16^18] before the identity of the IGFBP-4 proteinase
was known, the mechanistic basis for the requirement of IGF
has not been de¢ned. On one hand, IGF might be required as
a co-factor for the activation of PAPP-A [18]. On the other
hand, it might be required that IGFBP-4 binds IGF in order
to become a substrate for PAPP-A [19].
We here show that PAPP-A is capable of cleaving IGFBP-
5, in addition to IGFBP-4, and we identify the PAPP-A cleav-
age site in IGFBP-5. Interestingly, proteolysis of IGFBP-5
occurs in the absence of IGF and is slightly inhibited by
IGF. This ¢nding prompted further analysis of the proteolysis
of IGFBP-4 by PAPP-A. The availability of highly puri¢ed
reagents has allowed us to distinguish between the two models
of IGF-dependent IGFBP-4 proteolysis.
2. Materials and methods
2.1. Tissue culture and protein expression
Human embryonic kidney 293T cells (293tsA1609neo) [20] were
cultured in high glucose Dulbecco’s modi¢ed Eagle’s medium with
10% fetal bovine serum, 2 mM glutamine, non-essential amino acids,
and gentamicin (Life Technologies). Cells (2.5U106 on 6 cm plates
containing 4 ml medium) were transfected by calcium phosphate co-
precipitation [21] with 10 Wg of empty vector, or constructs containing
cDNA encoding human PAPP-A [8], human IGFBP-4 [13], or human
IGFBP-5 [15]. The PAPP-A construct was based on pcDNA3.1+
(Invitrogen), and the IGFBP-4 and -5 constructs were both based
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on pcDNA3.1/Myc-His(-)A (Invitrogen), as detailed previously
[8,13,15]. 48 h post-transfection the supernatants contained approxi-
mately 10 Wg/ml of recombinant proteins. IGFBP-4 and -5 were both
expressed as C-terminally c-myc and His-tagged proteins, increasing
the molecular weights by 3.1 and 2.9 kDa, respectively. PAPP-A-con-
taining supernatants were harvested after 48 h and cleared by centri-
fugation. To facilitate puri¢cation, cells transfected with IGFBP-4 and
-5 cDNA were maintained for another 48 h in serum-free medium
(293 SFM II, Life Technologies).
2.2. Protein puri¢cation
Recombinant IGFBP-4 and -5 were both puri¢ed from serum-free
media by successive steps of (1) a⁄nity chromatography on a metal
chelate column (2 ml NTA-Sepharose, Pharmacia) charged with nick-
el ions, (2) gel ¢ltration in 50% formic acid (pH6 1) on a Superdex 75
HR 10/30 column (Pharmacia), and (3) reversed-phase high pressure
liquid chromatography (RP-HPLC) on a column (4U250 mm) of
Nucleosil C4 500-7 (Macherey-Nagel), as described recently for
IGFBP-5 [15]. The puri¢ed protein eluting from the RP-HPLC col-
umn was lyophilized and redissolved in 50 mM Tris, pH 7.5. The
amounts of puri¢ed proteins (approximately 100 Wg per run) were
determined by amino acid analysis [22]. Recombinant PAPP-A in
standard serum-containing medium was immobilized on protein G
agarose beads (Life Technologies) using a non-inhibitory PAPP-A
monoclonal antibody, 234-2 [23]. The beads were washed extensively
with PBS containing 1000 mM sodium chloride, and then equilibrated
with PBS. Immobilized PAPP-A was used directly (for experiments
shown in Figs. 3 and 4), or bound PAPP-A was eluted with 200 mM
glycine, 1 mM calcium chloride, pH 3.0, into 1 M Tris to a ¢nal pH of
7.5 (for experiments shown in Fig. 2, 5, and 6). As evaluated by
reducing SDS^PAGE, a variable fraction (typically about 50%) of
the eluted PAPP-A was autocleaved and thus inactive, as recently
reported [13]. The concentration of PAPP-A (40 ng/Wl) was deter-
mined by amino acid analysis [24].
2.3. Measurement of proteolytic activity
Proteolysis of puri¢ed 125I-labeled IGFBP-4 or -5 was carried out in
50 mM Tris, pH 7.5, as described for IGFBP-5 [15] and IGFBP-4 [13],
using 0.3 ng PAPP-A (1 Wl of a culture supernatant containing about
8 Wg/ml PAPP-A, diluted approximately 25 times in PBS), and 50 000
cpm of the binding proteins per lane (approximately 5 ng) (Fig. 1).
The total reaction volume was 20 Wl. Incubation at 37‡C was carried
out with or without the addition of 40 nM IGF-II (Bachem), and with
PAPP-A polyclonal antibodies (A0230, DAKO, Denmark, diluted
1:20 to 0.4 mg Ig per ml) or irrelevant antibodies (anti-K2-macro-
globulin, A0033, DAKO) at the same concentration as speci¢ed.
The reaction mixture was analyzed by non-reducing SDS^PAGE
(16%) followed by autoradiography. For quantitative analysis (Figs.
2, 5, and 6), puri¢ed PAPP-A (10^30 ng) eluted from beads was used,
and 1 Wg unlabeled IGFBP-4 or -5 was added. The degree of cleavage
was determined by measuring band intensities with a PhosphorImager
(Molecular Dynamics) [13]. Medium from mock-transfected cells was
processed similarly to serve as a negative control to be subtracted
from all values. In other experiments (Figs. 3 and 4), using larger
amounts of proteins, the proteolysis of puri¢ed IGFBP-4 and -5
was performed with immobilized PAPP-A in 50 mM Tris, pH 7.5,
with or without added IGF-II. The amounts of protein used and the
length of incubation are speci¢ed in the text. Cleavage was assessed by
non-reducing SDS^PAGE (16%) followed by Coomassie staining.
2.4. Miscellaneous procedures
SDS^PAGE was performed in Tris^glycine gels (10^20% or 16%)
[25]. For cleavage-site determination, a⁄nity puri¢ed IGFBP-5 (20
Wg) was digested (37‡C, 2 h) with immobilized PAPP-A (approxi-
mately 1 Wg). Edman degradation of protein (s 50 pmol) separated
by SDS^PAGE and blotted onto a polyvinylidene £uoride (PVDF)
membrane was performed as described earlier [26]. IGF-I and -II
(Bachem) were 125I-labeled [27] using lactoperoxidase [28] rather
than chloramin-T. To evaluate the binding of IGF to IGFBP-4 and
PAPP-A, radiolabeled IGF-I or -II (approximately 40 000 cpm con-
tained in 10 Wl) was incubated (1 h at room temperature) with proteins
immobilized to protein G agarose (20 Wl) via monoclonal anti-c-myc
(clone 9E10, ATTC) or PAPP-A mAb 234-2, respectively. The
amounts of PAPP-A and IGFBP-4 bound per 20 Wl protein G beads
were 0.9 Wg and 0.1 Wg, respectively, corresponding to the same molar
amounts. Prior to incubation, PBS containing 0.1% bovine serum
albumin (BSA) was added to obtain a ¢nal volume of 300 Wl. The
amount of bound IGF following four rounds of washing in Eppen-
dorf tubes with PBS/0.1% BSA (500 Wl) was determined using a
Q counter. A variant of this experiment was carried out in which
unlabeled IGFBP-4 (0.1 Wg) was added, and inactive PAPP-A
(E483Q) [13] was used rather than wild-type PAPP-A to prevent
cleavage of IGFBP-4.
3. Results and discussion
3.1. PAPP-A cleaves IGFBP-5
We have found that in addition to IGFBP-4, PAPP-A is
capable of cleaving IGFBP-5 (Fig. 1). Like IGFBP-4, IGFBP-
5 is apparently cleaved into two fragments of similar size.
Surprisingly, in contrast to the proteolysis of IGFBP-4, the
cleavage of IGFBP-5 by PAPP-A occurs without the addition
of IGF (Fig. 1, lanes 2 and 3 vs. 5 and 6). The radiolabeled
binding proteins used for these experiments had been sub-
jected to gel ¢ltration at pH6 1 to ensure the absence of
contaminating IGF [15,29]. However, PAPP-A contained in
medium with 10% fetal bovine serum was diluted in bu¡er
and added to the reaction mixture (5000 times ¢nal dilution
compared to undiluted bovine serum), inarguably introducing
traces of IGF into the system. But, because these traces were
not su⁄cient to allow proteolysis of IGFBP-4 (Fig. 1, lane 2),
we draw the provisional conclusion (further addressed below,
see Section 3.3) that proteolysis of IGFBP-5 does not depend
on IGF.
A time course experiment showed that IGFBP-5 and -4 are
cleaved with similar rates by PAPP-A in the presence of IGF-
II, although IGFBP-5 consistently disappeared faster initially
(Fig. 2).
Previously, it was suggested that PAPP-A did not degrade
IGFBP-5 based on the lack of inhibition of IGFBP-5 proteo-
Fig. 1. PAPP-A proteolysis of IGFBP-4 and -5 visualized by non-re-
ducing SDS^PAGE followed by autoradiography. Radiolabeled
IGFBP-4 was incubated (16 h) with medium from cells transfected
with empty vector (lane 1), or with medium from cells transfected
with PAPP-A cDNA in the absence (lane 2) and presence (lane 3)
of added IGF-II. Likewise, radiolabeled IGFBP-5 was incubated (16
h) with medium from cells transfected with empty vector (lane 4),
or with medium from cells transfected with PAPP-A cDNA in the
absence (lane 5) and presence (lane 6) of IGF-II, and with PAPP-A
polyclonal antibodies in the presence of IGF-II (lane 7). Irrelevant
antibodies at the same concentration did not inhibit proteolysis (not
shown). The concentration of PAPP-A was 0.07 nM, the concentra-
tion of the binding proteins were 9 nM, and the concentration of
IGF-II was 40 nM. The absence (3) or presence (+) of IGF-II is
indicated below each lane. The C-terminal tag on both of the bind-
ing proteins causes their cleavage products to co-migrate, and thus
appear as one band. Both binding proteins show faint, less abun-
dant, glycosylation variants of higher molecular weight.
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lytic activity in ovarian follicular £uid using polyclonal anti-
bodies [7], but other results have pointed at PAPP-A as a
possible IGFBP-5 proteinase in non-fractionated pregnancy
serum [30]. We ¢nd here that PAPP-A proteolysis of
IGFBP-5 can be inhibited by polyclonal PAPP-A antibodies
(Fig. 1, lane 7). However, e⁄cient inhibition required more
antibody than inhibition of IGFBP-4 proteolysis [6], probably
re£ecting that antibody binding to overlapping, but non-iden-
tical sets of PAPP-A epitopes abrogate proteolysis of IGFBP-
4 and -5, respectively, and that not all epitopes can be occu-
pied by antibody at the same time.
3.2. Cleavage site determination
For determination of the PAPP-A cleavage site, IGFBP-5
(Fig. 3, lane 1) was digested with PAPP-A and separated by
SDS^PAGE (Fig. 3, lane 2). Edman degradation of digested,
blotted material showed two sequences of IGFBP-5,
K(144)FVGG and L(1)GXFV (N-terminus of mature
IGFBP-5), demonstrating that PAPP-A cleaves IGFBP-5 be-
tween Ser-143 and Lys-144, (R137KKLTQSsKFVGGAE).
Sequence analysis directly on the reaction mixture, without
prior separation by SDS^PAGE, showed no other sequences,
verifying that cleavage occurs only at one site. Comparison
with the reported IGFBP-4 cleavage site of PAPP-A
(S129TSGGKMsKVNGAPR) [31], shows that a Lys residue
is present in both of the P1P positions, hydrophobic residues
occupy the P2P positions, and a Gly residue is present in both
P4P positions. Interestingly, PAPP-A2 has recently been found
to cleave IGFBP-5 at the same site [15].
3.3. IGF does not promote proteolysis of IGFBP-5 by PAPP-A
Although the cleavage of IGFBP-5 by PAPP-A appeared
independent of IGF (Fig. 1), we further asked whether it
would occur in the absence of possible traces of IGF (see
Section 3.1), and whether the rate of proteolysis would be
a¡ected by IGF. Using both IGFBP-5 and PAPP-A in highly
puri¢ed forms, we thus compared partial digests with and
without IGF-II (Fig. 4A). This experiment demonstrates
that the proteolysis of IGFBP-5 by PAPP-A does not depend
on IGF and is not dramatically a¡ected by its presence. Sev-
eral previous studies [32^34] have reported moderate inhibi-
tion of IGFBP-5 proteolysis by IGF. To evaluate whether
IGFBP-5 proteolysis by PAPP-A was also inhibited by IGF,
we performed a time course experiment in the presence and
Fig. 2. Degradation of IGFBP-4 (¢lled circles) and IGFBP-5 (¢lled
squares) by PAPP-A as a function of time. Puri¢ed PAPP-A (15 ng,
0.3 nM) was incubated with IGFBP-4 or -5 (1 Wg, 144 nM and 130
nM, respectively), in the presence of excess IGF-II (0.3 Wg, 167
nM). Trace amounts of radiolabeled IGFBP-4 or -5 were added to
allow quanti¢cation of cleavage. The total reaction volumes were
240 Wl. Samples were taken out at various time points, and the de-
gree of cleavage was determined by densiometry after separation by
SDS^PAGE. The insert shows one lane of IGFBP-4 and -5 after 45
min of incubation (intact binding proteins (i) and cleavage products
(c) are indicated). Values are average of three independent experi-
ments þ standard deviation. Similar curves were obtained with
PAPP-A ¢rst incubated alone for 4 h at 37‡C (not shown).
Fig. 3. Preparative digest of IGFBP-5 for determination of the
PAPP-A cleavage site. Puri¢ed IGFBP-5 (10 Wg) was digested with
immobilized PAPP-A. A fraction (1 Wg) of the reaction mixture
(lane 2) and the same amount of undigested IGFBP-5 (lane 1) is
shown. Edman degradation of the cleavage products blotted onto
PVDF membrane showed that cleavage occurs between Ser-143 and
Lys-144 of IGFBP-5. The two distinct cleavage bands (just above
20 kDa) are both C-terminal fragments that di¡er in size due to
glycosylation. The N-terminal fragment does not appear as a dis-
tinct band, but rather co-migrates as a smear around the two C-ter-
minal fragments.
Fig. 4. E¡ect of added IGF on partial proteolysis of IGFBP-5 and
-4. A: Puri¢ed IGFBP-5 (1 Wg, 694 nM) was digested (2 h) partially
with puri¢ed PAPP-A (0.1 Wg, 11 nM) in the absence (lane 1) and
presence (lane 2) of 500 nM IGF-II, showing that IGFBP-5 proteol-
ysis by PAPP-A does not depend on IGF. The total reaction vol-
ume was 45 Wl. B: Puri¢ed IGFBP-4 (1 Wg, 766 nM) was digested
(8 h) partially with puri¢ed PAPP-A (0.1 Wg, 11 nM) in the absence
(lane 1) and presence (lane 2) of 500 nM IGF-II. This shows that
IGFBP-4 proteolysis by PAPP-A can occur in the absence of IGF,
although it is promoted by IGF. The total reaction volume was 45
Wl. Both gels are stained with Coomassie blue. The positions of in-
tact (i) and cleaved (c) IGFBP-5 and -4 are indicated.
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absence of IGF (Fig. 5). This clearly shows an inhibitory
e¡ect of added IGF, not evident from the previous experiment
(Fig. 4A).
3.4. The role of IGF in proteolysis of IGFBP-4 by PAPP-A
The above ¢ndings have implications for the mechanism of
IGF-dependent IGFBP-4 proteolysis [16^18], suggesting that
PAPP-A is not activated by binding of IGF: because PAPP-A
cleaves IGFBP-5 in the absence of IGF, and because proteol-
ysis is not promoted by IGF, it is not likely that IGF activates
PAPP-A or modulates its enzymatic activity towards IGFBP-
4 ^ another substrate of the same enzyme. This could not
previously be ruled out [18]. Therefore, the alternative model
[19] that IGF binding to IGFBP-4 induces a conformational
change that causes it to become a substrate for PAPP-A is
more probable. In this model it is still possible that both
components of the complex of IGF and IGFBP-4 interacts
directly with PAPP-A.
Previous di⁄culties in discriminating between the two mod-
els of IGF-dependent IGFBP-4 proteolysis were caused ¢rstly
by not knowing the identity of the proteinase, secondly by its
availability in only limited quantities that were not puri¢ed
[6]. We thus asked whether cleavage of IGFBP-4 in the ab-
sence of IGF would occur using higher concentrations of pu-
ri¢ed enzyme and substrate. Cleavage of IGFBP-4 did occur
(Fig. 4B, lane 1), and, as expected, added IGF-II increased the
degree of proteolysis (Fig. 4B, lane 2). Compared to the stan-
dard experiment in which PAPP-A does not degrade IGFBP-4
without IGF (Fig. 1), the concentrations of both PAPP-A and
IGFBP-4 were increased about 100-fold in this experiment
(see ¢gure legends for concentrations).
To more quantitatively determine the e¡ect of IGF on pro-
teolysis, a time course experiment using highly puri¢ed pro-
teins in the absence and presence of IGF-II was performed
(Fig. 6). This quantitatively illustrates the dramatic increase in
proteolysis of IGFBP-4 caused by IGF: within the ¢rst 2 h of
digestion it promotes the proteolysis 20-fold or more. It is
thus questionable if IGF-independent IGFBP-4 proteolysis
plays a role in vivo.
3.5. IGF does not bind to PAPP-A
Finally, by incubating radiolabeled IGF-II with immobi-
lized PAPP-A or IGFBP-4, we demonstrated that PAPP-A
does not bind directly to IGF-II (Table 1). Labeled IGF-II
e⁄ciently binds to IGFBP-4, but no binding to PAPP-A was
observed. Further, no binding of radiolabeled IGF-II to an
inactive mutant of PAPP-A (Glu-483 substituted with Gln)
[13] was observed in the presence of IGFBP-4 (not shown).
Similar results were obtained with IGF-I (not shown).
Our ¢nding that proteolysis of IGFBP-4 by PAPP-A can
Fig. 5. Measurement of the e¡ect of IGF on IGFBP-5 proteolysis
by PAPP-A. Puri¢ed PAPP-A (10 ng, 0.2 nM) was incubated with
IGFBP-5 (1 Wg, 130 nM) in the absence (open squares) or presence
(¢lled squares) of excess IGF-II (0.3 Wg, 167 nM). Trace amounts of
radiolabeled IGFBP-5 were added to allow quanti¢cation of cleav-
age. The total reaction volumes were 240 Wl. Samples were taken
out at various time points, and the degree of cleavage was deter-
mined by densiometry after separation by SDS^PAGE. Values are
average of two independent experiments þ standard deviation.
Fig. 6. Measurement of the e¡ect of IGF on IGFBP-4 proteolysis
by PAPP-A. Puri¢ed PAPP-A (30 ng, 0.6 nM) was incubated with
IGFBP-4 (1 Wg, 144 nM) in the absence (open circles) or presence
(¢lled circles) of excess IGF-II (0.3 Wg, 167 nM). Trace amounts of
radiolabeled IGFBP-4 were added to allow quanti¢cation of cleav-
age. The total reaction volumes were 240 Wl. Samples were taken
out at various time points, and the degree of cleavage was deter-
mined by densiometry after separation by SDS^PAGE. The insert
shows lanes of IGFBP-4 without PAPP-A, and with PAPP-A, in
the absence or presence of IGF-II after 3 h of incubation (intact
binding proteins (i) and cleavage products (c) are indicated). Values
are average of three independent experiments þ standard deviation.
Table 1
Binding of radiolabeled IGF-II to immobilized PAPP-A and IGFBP-4
Beadsa Immobilized proteinb Radioactivity (cpm)c % Boundd
Protein G-anti-PAPP-A control 58 0.68
Protein G-anti-PAPP-A PAPP-A 47 0.55
Protein G-anti-c-myc control 29 0.34
Protein G-anti-c-myc IGFBP-4-c-myc 8531 100
aAgarose beads with monoclonal antibody against PAPP-A (234-2) or the c-myc epitope (9E10) were prepared.
bBeads with bound antibody were saturated with medium from cells transfected with empty vector (control), or with PAPP-A or IGFBP-4-c-
myc cDNA to contain equimolar amounts of PAPP-A and IGFBP-4. The beads were washed with PBS prior to the addition of radiolabeled
IGF-II.
cRadioactivity after washing with PBS. Background (25 cpm) is subtracted.
dComparison of radioactivity bound to immobilized IGFBP-4. The radiolabeled IGF bound to IGFBP-4 represents the functional fraction of
the labeled IGF.
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occur in the absence of IGF (Fig. 4B), although it is relatively
slow (Fig. 6), does not fully discriminate between the two
models of IGF-dependent IGFBP-4 proteolysis. The fact
that PAPP-A cleaves IGFBP-5 in the absence of IGF, and
that this reaction is not enhanced by IGF (Fig. 4A), strongly
suggests that PAPP-A does not require activation by IGF.
However, by also demonstrating that PAPP-A does not
bind IGF, we can de¢nitively conclude that IGF binds
IGFBP-4, which then becomes a (better) PAPP-A substrate.
3.6. Concluding remarks
We have demonstrated a second substrate for PAPP-A,
IGFBP-5. Proteolysis of IGFBP-5 does not require the pres-
ence of IGF, and is not promoted by the presence of IGF.
PAPP-A cleaves IGFBP-5 at the same site as PAPP-A2, be-
tween Ser-143 and Lys-144. We further found that, in contrast
to common belief, PAPP-A is capable of cleaving IGFBP-4 in
the absence of IGF. The rate of hydrolysis, however, is very
slow and increases dramatically in the presence of IGF. Be-
cause PAPP-A is unable to bind IGF, we conclude that IGF
enhances proteolysis by binding to IGFBP-4, not by interac-
tion with PAPP-A. PAPP-A, IGFBP-4, and IGFBP-5 are
present at the same time in several tissues. Further studies
are required to delineate the dynamics of proteolysis of
IGFBP-4 and -5 by PAPP-A. In addition to the concentration
of IGFs, at least concentrations of individual components and
relative a⁄nities for the IGFs must be considered. In several
biological £uids PAPP-A appears to be the only IGFBP-4
proteinase. Likewise, PAPP-A may be the only IGFBP-5 pro-
teinase in some systems.
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